Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00158327 · ClinicalTrials.gov registry record · Phase 3
Telephone-Based Care Management Program for Individuals With Anxiety Disorders
A Phase 3 study of Anxiety Disorders and Panic Disorder, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 3
- Development phase
- 360
- Enrollment target
- 1
- Study location
NCT00158327: Completed Phase 3 study of Anxiety Disorders and Panic Disorder, sponsored by University of Pittsburgh.
NCT00158327 is a Phase 3 study of Anxiety Disorders and Panic Disorder that has completed, run by University of Pittsburgh. The registered enrollment target is 360 participants, below the 1,136-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00158327, a Phase 3 study of Anxiety Disorders and Panic Disorder, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 360 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine the impact of a telephone-based care management program for primary care patients with panic disorder or generalized anxiety disorder.
Conditions Studied
Interventions
- BEHAVIORAL Usual care
- BEHAVIORAL Telephone-based collaborative care
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2004-03 |
| Est. Completion | 2011-02 |
| Phase | Phase 3 |
What the finished NCT00158327 record still lists
NCT00158327 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 1,136-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (68% lower).
The record links to 2 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.
NCT00158327 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00158327 about?
NCT00158327 is a clinical study titled "Telephone-Based Care Management Program for Individuals With Anxiety Disorders". This study will determine the impact of a telephone-based care management program for primary care patients with panic disorder or generalized anxiety disorder.
What is the current status of trial NCT00158327?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 360 participants. The study started on 2004-03. Estimated completion is 2011-02.
What conditions does trial NCT00158327 study?
This clinical trial studies the following conditions: Anxiety Disorders, Panic Disorder.
What interventions are being tested in trial NCT00158327?
The interventions under investigation include: Usual care (BEHAVIORAL), Telephone-based collaborative care (BEHAVIORAL).
Who is sponsoring clinical trial NCT00158327?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00158327 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00158327's enrollment target sits among peer trials
360 17th of 84 higher than 68 of 84 other Anxiety Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder
RECRUITING · Phase 3
-
Fluoxetine vs CBT in Childhood Anxiety Disorders
ACTIVE NOT RECRUITING · Phase 3
-
A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder
COMPLETED · Phase 3
-
Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS
COMPLETED · Phase 3
-
Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)
COMPLETED · Phase 3
-
School-based Treatment for Anxious Children
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia